¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hypertrophy, benign prostatic"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypertrophy
    ºñ´ë
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • physiologic hypertrophy
    »ý¸®Àûºñ´ë
  • papillomatous hypertrophy
    À¯µÎÁ¾¸ð¾çºñ´ë
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë, °¡¼º±ÙÀ°ºñ´ë
  • ventricular hypertrophy
    ½É½Çºñ´ë
  • vicarious hypertrophy
    ´ë»óºñ´ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë
  • symmetric hypertrophy
    ´ëĪºñ´ë
  • true hypertrophy
    Áø¼ººñ´ë
  • ventricular hypertrophy
    ½É½Çºñ´ë
  • vicarious hypertrophy
    ´ë»óºñ´ë
  • nail hypertrophy onychauxis
    ¼Õ¹ßÅéºñ´ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • prostatic calculus
    Àü¸³¼±°á¼®(îñí¡àÍ Ì¿à´)
  • prostatic cancer
    Àü¸³¼±¾Ï.
  • prostatic capsule
    Àü¸³»ùÇǸ·
  • prostatic concretion
    Àü¸³»ùµ¹
  • prostatic concretion
    Àü¸³¼±°á¼®(îñí¡àÍ Ì¿à´)
  • prostatic cyst
    Àü¸³¼±³¶
  • prostatic duct
    Àü¸³»ù°ü, Àü¸³¼±°ü.
  • prostatic duct
    Àü¸³»ù°ü
  • prostatic ductule
    Àü¸³»ù¼¼°ü
  • prostatic fluid
    Àü¸³¼±¾×(îñí¡àÍäû).
  • prostatic fossa
    Àü¸³¼±¿Í
  • prostatic gland
    Àü¸³»ù
  • prostatic intraepithelial neoplasia
    Àü¸³¼±»óÇdz»Á¾¾ç(îñí¡àÍß¾ù«Ò®ðþåË)
  • prostatic part
    Àü¸³»ùºÎºÐ
  • prostatic part of urethra
    ¿äµµÀü¸³»ùºÎºÐ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • tumor,benign
    ¾ç¼º
  • vertigo, benign paroxysmal positional
    ¾ç¼º¹ßÀÛ(¼º)µÎÀ§ Çö±â
  • buds of prostatic gland
    Àü¸³»ù½Ï
  • ductules of prostatic gland
    Àü¸³»ù°ü
  • medial prostatic notch
    ³»ÃøÀü¸³¼±ÀýÈç(¡­îñ í¡àÍôîýÝ).
  • prostatic
    Àü¸³¼±(îñí¡àÍ)ÀÇ.
  • prostatic
    Àü¸³¼±ÀÇ
  • prostatic abscess
    Àü¸³¼±³ó¾ç(¡­ÒÛåË).
  • prostatic abscess
    Àü¸³¼±³ó¾ç(îñí¡àÍÒÛåË)
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • prostatic adenoma
    Àü¸³¼±¼±Á¾
  • prostatic artery
    Àü¸³¼±µ¿¸Æ
  • prostatic branches
    Àü¸³»ù°¡Áö
  • prostatic calculus
    Àü¸³¼±°á¼®(¡­Ì¿à´).
  • prostatic calculus
    Àü¸³¼±°á¼®(îñí¡àÍ Ì¿à´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
PF pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid...
PIF paratoid isoelectric focusing variant protein; peak inspiratory flow; proinsulin-free; prolactin-inh...
PM after death (Lat. post mortem); after noon [Lat. post meridiem]; mean pressure; pacemaker; pantomogr...
pros prostate, prostatic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RVH Right ventricular hypertrophy
BBD Benign Breast Disease
BCECT Benign Childhood Epilepsy with Centrotemporal Spike
BFNC Benign Familial Neonatal Convulsions
BIH Benign Intracranial Hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • benign giant cell tumor
    ¾ç¼º °Å´ë¼¼Æ÷ Á¾¾ç
    1. °ñÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. °ñÀÇ ¾ç¼º Á¾¾çÀÇ Çϳª·Î ³ë¾àÀÚ¿¡°Ô ¸¹À¸¸ç ¹ß»ý ºÎÀ§´Â Àå°ü°ñÀÇ °ñ´Ü¿¡ ¸¹ÀÌ ³ªÅ¸³­´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¿øÇü, ¹æÃßÇüÀÌ ÀÖ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆÄ°ñ¼¼Æ÷¿Í À¯»çÇÑ °Å´ë¼¼Æ÷°¡ È¥ÀçÇÑ´Ù. 2. °ÇÃÊÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. º»·¡ Á¾¾çÀÌ ¾Æ´Ï¸ç, °áÁ¤¼º °ÇÃÊ¿°À» °¡¸®Å°¸ç °ÇÃÊÀÇ ¼¶À¯¼º Á¶Á÷±¸Á¾¿¡ Æ÷ÇԵȴÙ.
  • benign juvenile melanoma
    ¾ç¼º À¯³â¼º Èæ»öÁ¾
    ¾ç¼º, À¶±â¼ºÀÌ¸ç ´Ü´ÜÇϰí ÇÎÅ©»ö ³»Áö ÀÚÀû»öÀ» ¶í ±¸ÁøÀÌ¸ç ´ë°³ ¾à°£ ³«¼³ ¼³Ç¥¸éÀ» °®°í, ÀϹÝÀûÀ¸·Î ¾ó±¼ ƯÈ÷ »´¿¡ ¹ß»ýÇÏ¸ç »çÃá±â Àü¿¡ ¹ßº´ÇÏ´Â °æ¿ì°¡ ¸¹´Ù.
  • benign lymphangioendothelioma
    ¾ç¼º ¸²ÇÁ ³»ÇÇ ¼¼Æ÷Á¾
  • benign lymphoepithelial lesion
    ¾ç¼º ¸²ÇÁ »óÇǼº º´¼Ò
    Ÿ¾×¼±ÀÇ ½ÇÁú Á¶Á÷¿¡ ¸²ÇÁ±¸µéÀÌ Ä§À±µÇ¸é¼­ ¼±¹æ ¼¼Æ÷µéÀÌ ÆÄ±«µÇ°í »óÇDZ٠»óÇǵµ¶ó´Â ƯÀÌÇÑ Á¶Á÷ÇÐÀû ±¸Á¶¹°À» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ» ¸»ÇÑ´Ù. Çö¹Ì°æ ¼Ò°ß¿¡¼­´Â ¿±»ó ±¸Á¶´Â Àß º¸Á¸µÇ¾î ÀÖÀ¸¸é¼­ ¿©Æ÷¸¦ °¡Áø ¸²ÇÁ Á¶Á÷ÀÌ Å¸¾×¼±ÀÇ ½ÇÁú Á¶Á÷À» ´ëÄ¡½Ã۰í, ±ºµ¥±ºµ¥¿¡ »êÀçµÇ¾î ÀÖ´Â »óÇDZ٠»óÇǵµµéÀ» º¼ ¼ö ÀÖ´Ù. ±Ù »óÇÇÀÇ Áõ½ÄÀº Áø´ÜÇÐÀûÀ¸·Î Áß¿äÇϸç ÀÌ·± »óÇDZ٠»óÇǵµ³»¿¡ ÀÖ´Â ÃÊÀÚ¾ç ¹°ÁúÀº ¹Ì¼¼±¸Á¶ÀûÀ¸·Î ±âÀú¸· ¹°Áú·Î µÇ¾î ÀÖ´Ù.
  • benign lymphoid hyperplasia
    ¾ç¼º ¸²ÇÁ °úÇü¼º
  • benign melanocytic tumor
    ¾ç¼º ¸á¶ó´Ñ ¼¼Æ÷Á¾
  • benign migratory glossitis
    ¾ç¼º À̵¿¼º ¼³¿°, ¾ç¼º ÀÌÁÖ¼º ¼³¿°, ¾ç¼º ÀüÀ̼º ¼³¿°
    1. ¸ð»óÀ¯µÎ°¡ ¼Ò½ÇµÇ°í º´¼ÒÀÇ º¯¿¬ÀÌ °ú°¢È­µÇ¸ç, »óÇÇÃþ¿¡ ÀÛÀº ³ó¾çÀÌ º¸ÀδÙ. °íÀ¯ÆÇ¿¡µµ ¿°Áõ ¼¼Æ÷°¡ ħÀ±ÇÑ´Ù. ¹«Å뼺À̳ª ¶§·Î´Â µ¿ÅëÀ» º¸À̰í Àڱؿ¡ ¹Î°¨ÇÏ°Ô ¹ÝÀÀÇÑ´Ù. 2. ¼³¸éÀÇ Áöµµ»óÀÇ Àû»ö ¹ÝÁ¡ÀÇ À̵¿ÀÌ ÀÖ´Ù. ¿©¼º¿¡ È£¹ßÇÑ´Ù.
  • benign mucous membrane pemphigoid
    ¾ç¼º Á¡¸· À¯ÃµÆ÷â
  • benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
    °íÇ÷¾ÐÀÇ ¾ç¼º ±â¿¡ ³ªÅ¸³ª´Â ½ÅÀå º¯È­¸¦ ³ªÅ¸³»´Â ¿ë¾î. ¼¼µ¿¸Æ¿¡¼­ À¯¸®¾ç °æÈ­ÁõÀ» º¸ÀÌ°í ºñ·Ï ¹Ì¾àÇÏÁö¸¸ ¾î´À Á¤µµÀÇ ¾ç¼º ½Å °æÈ­ÁõÀº 60¼¼ ÀÌ»óÀÇ ºÎ°Ë ½Ã ÀÚÁÖ °üÂûÇÒ ¼ö ÀÖ´Ù. Ç÷¾ÐÀÌ Á¤»óÀÎ »ç¶÷¿¡¼­µµ °íÇ÷¾ÐÀ̳ª ´ç´¢º´ÀÌ ÀÖ´Â °æ¿ì´Â ´õ¿í ºó¹øÇÏ°í ½ÉÇÑ º´º¯À» º¼ ¼ö ÀÖ´Ù. ½ÅÀåÀÇ Å©±â´Â Á¤»óÀ̰ųª ÁÙ¾îµé ¼ö ÀÖÀ¸¸ç Ç¥¸é¿¡ ÀÛÀº °ú¸³¼ºÀÇ ÇÔ¸ôµÈ Ç¥¸éÀÌ °üÂûµÈ´Ù. ½ÅÀå ±â´ÉÀÇ ÀúÇϳª ´¢µ¶ÁõÀº ÃÊ·¡ÇÏÁö ¾ÊÀ¸¸ç ÀϹÝÀûÀ¸·Î ½Å Ç÷·ù·®ÀÇ °¨¼Ò´Â ÀÖ´Ù. ±×·¯³ª GFRÀº °¨¼ÒÇÏÁö ¾Ê°í °æ¹ÌÇÑ ´Ü¹é´¢´Â ÀÖÀ» ¼ö ÀÖ´Ù. Àå±â°£ Áö¼ÓµÈ ¾ç¼º °íÇ÷¾Ð ȯÀÚÀÇ ¾à 5% À̳»¿¡¼­ ½ÅºÎÀüÀÌ ¿Ã ¼ö Àִµ¥ ´ëºÎºÐÀÌ °íÇ÷¾ÐÀÇ accelerated
  • benign neurocutaneous melanomatosis
    ¾ç¼º ½Å°æ ÇÇºÎ Èæ»öÁ¾Áõ
  • benign papular acantholytic dermatosis
    ¾ç¼º ±¸Áø¼º ±Ø¼¼Æ÷ ÇØ¸® ÇǺκ´
  • benign paroxysmal positional vertigo
    ¾ç¼º ¹ßÀÛ µÎÀ§ Çö±âÁõ, ¾ç¼º ¹ßÀÛ¼º µÎÀ§ Çö±âÁõ, ¾ç¼º ¹ßÀÛ¼º üÀ§¼º Çö±âÁõ
    Àç¹ß¼º ¾îÁö·¯¿ò°ú ¾È±¸ ÁøÅÁÀÌ ¸Ó¸®¸¦ ÀÏÁ¤ÇÑ À§Ä¡¿¡ µÎ¾úÀ» ¶§ ÀϾ´Â °Í.
  • benign synovioma
    ¾ç¼º Ȱ¸·Á¾
    Ȱ¸·¿¡ ±â¿øÇÑ ¾ç¼º Á¾¾ç.
  • benign vascular tumor
    ¾ç¼º Ç÷°üÁ¾
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
haemangiectatic hypertrophy <syndrome> A congenital malformation syndrome characterised by the triad of asymmetric limb hypertrophy, haemangiomata, and nevi. Asymmetric limb hypertrophy is enlargement of one limb and not the corresponding limb on the other side, the enlarged limb being 3 times more likely to be a leg than an arm in ktw; and the limb enlargement is of bone as well as soft tissue. The haemangiomas, abnormal nests of blood vessels that proliferate inappropriately and excessively, cover a remarkable range from small innocuous capillary haemangiomas ( strawberry marks ) to huge cavernous haemangiomas. The nevi are pigmented moles on the skin; in ktw there are often also dark linear streaks on the skin, streaks due to too much pigment. There can be other abnormalities but the triad is the consistent clinical centrepiece of the disease. most persons with ktw have an enlarged leg and do relatively well without treatment or, for example, with only compression from an elastic stocking. Skin ulcers and other skin problems can occur over the swollen leg. Usually, the treatment is conservative. Surgery is almost never needed. The only possible exceptions are the very rare situations in which the leg reaches gigantic proportions or secondary clotting difficulties arise (due to trapping and destruction of blood platelets in a huge haemangioma). Then, amputation may become necessary. The cause of ktw syndrome is unknown.
(12 Dec 1998)
simple hypertrophy Increase in size of cells.
(05 Mar 2000)
simulated hypertrophy Increased size of a part due to continued growth unrestrained by attritions, as is seen in the case of the teeth of certain animals when the opposing teeth have been destroyed.
(05 Mar 2000)
hypertrophy The enlargement or overgrowth of an organ or part due to an increase in size of its constituent cells.
Compare: hyperplasia.
Origin: Gr. Troph = nutrition
(18 Nov 1997)
hypertrophy, left ventricular Enlargement of the left ventricle of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
(12 Dec 1998)
hypertrophy, right ventricular Enlargement of the right ventricle of the heart. This increase in ventricular mass is often attributed to pulmonary hypertension and is a contributor to cardiovascular morbidity and mortality.
(12 Dec 1998)
numerical hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
quantitative hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
eccentric hypertrophy Thickening of the wall of the heart or other cavity, with dilation.
(05 Mar 2000)
endemic hypertrophy Enlargement of the calcaneus preceded by fever and pain in the heel, reported from the Gold Coast (now Ghana) and in Taiwan among the indigenous population.
(05 Mar 2000)
true hypertrophy An increase in size involving all the different tissues composing the part.
(05 Mar 2000)
false hypertrophy Increase in size of an organ or a part, due not to increase in size or number of the specific functional elements but to that of some other tissue, fatty or fibrous.
Synonym: false hypertrophy.
(05 Mar 2000)
left ventricular hypertrophy <radiology> Coarctation, aortic stenosis
(12 Dec 1998)
functional hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
lipomatous hypertrophy Nonencapsulated adipose tissue forming a lipoma-like mass, usually in the cardiac interatrial septum where it may cause arrhythmia and sudden death.
Synonym: lipomatous hypertrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á